COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 |
| | | VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY |
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Abbott Laboratories | Common | 002824100 | 36,815 | 466,550 | SH | | SOLE | | 466,550 | 0 | 0 |
AbbVie Inc. | Common | 00287Y109 | 25,974 | 340,916 | SH | | SOLE | | 340,916 | 0 | 0 |
ABIOMED, Inc. | Common | 003654100 | 4,285 | 29,516 | SH | | SOLE | | 29,516 | 0 | 0 |
AC Immune SA | Shares | H00263105 | 1,187 | 171,813 | SH | | SOLE | | 171,813 | 0 | 0 |
Acadia Healthcare Company, Inc. | Common | 00404A109 | 2,408 | 131,200 | SH | | SOLE | | 131,200 | 0 | 0 |
ACADIA Pharmaceuticals Inc. | Common | 004225108 | 9,363 | 221,599 | SH | | SOLE | | 221,599 | 0 | 0 |
Acceleron Pharma Inc. | Common | 00434H108 | 3,649 | 40,606 | SH | | SOLE | | 40,606 | 0 | 0 |
Aerie Pharmaceuticals, Inc. | Common | 00771V108 | 900 | 66,688 | SH | | SOLE | | 66,688 | 0 | 0 |
Aerpio Pharmaceuticals, Inc. | Common | 00810B105 | 142 | 257,554 | SH | | SOLE | | 257,554 | 0 | 0 |
Agilent Technologies, Inc. | Common | 00846U101 | 3,762 | 52,525 | SH | | SOLE | | 52,525 | 0 | 0 |
Agios Pharmaceuticals, Inc. | Common | 00847X104 | 6,633 | 186,964 | SH | | SOLE | | 186,964 | 0 | 0 |
Alcon Inc. | Ordinary Shares | H01301128 | 1,864 | 36,686 | SH | | SOLE | | 36,686 | 0 | 0 |
Alexion Pharmaceuticals, Inc. | Common | 015351109 | 37,113 | 413,326 | SH | | SOLE | | 413,326 | 0 | 0 |
Align Technology, Inc. | Common | 016255101 | 1,747 | 10,041 | SH | | SOLE | | 10,041 | 0 | 0 |
Alkermes plc | Shares | G01767105 | 2,450 | 169,930 | SH | | SOLE | | 169,930 | 0 | 0 |
Allakos Inc. | Common | 01671P100 | 2,865 | 64,397 | SH | | SOLE | | 64,397 | 0 | 0 |
Allergan plc | Shares | G0177J108 | 27,978 | 157,981 | SH | | SOLE | | 157,981 | 0 | 0 |
Allogene Therapeutics, Inc. | Common | 019770106 | 4,748 | 244,261 | SH | | SOLE | | 244,261 | 0 | 0 |
Alnylam Pharmaceuticals, Inc. | Common | 02043Q107 | 14,980 | 137,617 | SH | | SOLE | | 137,617 | 0 | 0 |
Amarin Corporation plc | Sponsored ADR | 023111206 | 2,415 | 603,791 | SH | | SOLE | | 603,791 | 0 | 0 |
AmerisourceBergen Corporation | Common | 03073E105 | 4,788 | 54,107 | SH | | SOLE | | 54,107 | 0 | 0 |
Amgen Inc. | Common | 031162100 | 121,612 | 599,871 | SH | | SOLE | | 599,871 | 0 | 0 |
Amicus Therapeutics, Inc. | Common | 03152W109 | 3,409 | 368,960 | SH | | SOLE | | 368,960 | 0 | 0 |
AnaptysBio, Inc. | Common | 032724106 | 1,671 | 118,261 | SH | | SOLE | | 118,261 | 0 | 0 |
Anthem, Inc. | Common | 036752103 | 14,887 | 65,568 | SH | | SOLE | | 65,568 | 0 | 0 |
Apellis Pharmaceuticals, Inc. | Common | 03753U106 | 4,648 | 173,494 | SH | | SOLE | | 173,494 | 0 | 0 |
ARCA biopharma, Inc. | Common | 00211Y506 | 100 | 36,068 | SH | | SOLE | | 36,068 | 0 | 0 |
Ardelyx, Inc. | Common | 039697107 | 3,455 | 607,698 | SH | | SOLE | | 607,698 | 0 | 0 |
Arena Pharmaceuticals, Inc. | Common | 040047607 | 1,176 | 28,002 | SH | | SOLE | | 28,002 | 0 | 0 |
argenx SE | Sponsored ADR | 04016X101 | 5,925 | 44,977 | SH | | SOLE | | 44,977 | 0 | 0 |
Arrowhead Pharmaceuticals, Inc. | Common | 04280A100 | 2,134 | 74,186 | SH | | SOLE | | 74,186 | 0 | 0 |
Ascendis Pharma A/S | Sponsored ADR | 04351P101 | 7,807 | 69,332 | SH | | SOLE | | 69,332 | 0 | 0 |
AstraZeneca PLC | Sponsored ADR | 046353108 | 12,331 | 276,098 | SH | | SOLE | | 276,098 | 0 | 0 |
Atreca, Inc. | Class A Common | 04965G109 | 5,833 | 352,424 | SH | | SOLE | | 352,424 | 0 | 0 |
Aurinia Pharmaceuticals Inc. | Common | 05156V102 | 1,317 | 90,788 | SH | | SOLE | | 90,788 | 0 | 0 |
Avadel Pharmaceuticals plc | Sponsored ADR | 05337M104 | 4,495 | 566,066 | SH | | SOLE | | 566,066 | 0 | 0 |
AVROBIO, Inc. | Common | 05455M100 | 1,165 | 74,874 | SH | | SOLE | | 74,874 | 0 | 0 |
Axonics Modulation Technologies, Inc. | Common | 05465P101 | 714 | 28,100 | SH | | SOLE | | 28,100 | 0 | 0 |
Axsome Therapeutics, Inc. | Common | 05464T104 | 1,858 | 31,591 | SH | | SOLE | | 31,591 | 0 | 0 |
Bausch Health Companies Inc. | Common | 071734107 | 1,835 | 118,412 | SH | | SOLE | | 118,412 | 0 | 0 |
Baxter International Inc. | Common | 071813109 | 7,890 | 97,183 | SH | | SOLE | | 97,183 | 0 | 0 |
Becton, Dickinson and Company | Common | 075887109 | 17,866 | 77,754 | SH | | SOLE | | 77,754 | 0 | 0 |
BeiGene, Ltd. | Sponsored ADR | 07725L102 | 9,231 | 74,984 | SH | | SOLE | | 74,984 | 0 | 0 |
Bellicum Pharmaceuticals, Inc. | Common | 079481404 | 28 | 6,000 | SH | | SOLE | | 6,000 | 0 | 0 |
Bio-Techne Corporation | Common | 09073M104 | 10,939 | 57,691 | SH | | SOLE | | 57,691 | 0 | 0 |
Biogen Inc. | Common | 09062X103 | 105,271 | 332,735 | SH | | SOLE | | 332,735 | 0 | 0 |
Biohaven Pharmaceutical Holding Company Ltd. | Common | G11196105 | 1,537 | 45,164 | SH | | SOLE | | 45,164 | 0 | 0 |
BioMarin Pharmaceutical Inc. | Common | 09061G101 | 22,867 | 270,613 | SH | | SOLE | | 270,613 | 0 | 0 |
bluebird bio, Inc. | Common | 09609G100 | 3,870 | 84,194 | SH | | SOLE | | 84,194 | 0 | 0 |
Blueprint Medicines Corporation | Common | 09627Y109 | 8,148 | 139,336 | SH | | SOLE | | 139,336 | 0 | 0 |
Boston Scientific Corporation | Common | 101137107 | 19,175 | 587,662 | SH | | SOLE | | 587,662 | 0 | 0 |
BridgeBio Pharma, Inc. | Common | 10806X102 | 1,138 | 39,228 | SH | | SOLE | | 39,228 | 0 | 0 |
Bristol-Myers Squibb Company | Common | 110122108 | 47,097 | 844,932 | SH | | SOLE | | 844,932 | 0 | 0 |
Bristol-Myers Squibb Company | Right | 110122157 | 5,600 | 1,473,710 | SH | | SOLE | | 1,473,710 | 0 | 0 |
Celldex Therapeutics, Inc. | Common | 15117B202 | 12 | 7,053 | SH | | SOLE | | 7,053 | 0 | 0 |
Cellectis | Sponsored ADR | 15117K103 | 1,013 | 110,147 | SH | | SOLE | | 110,147 | 0 | 0 |
Centene Corporation | Common | 15135B101 | 17,122 | 288,194 | SH | | SOLE | | 288,194 | 0 | 0 |
Cerner Corporation | Common | 156782104 | 5,134 | 81,500 | SH | | SOLE | | 81,500 | 0 | 0 |
Charles River Laboratories International, Inc. | Common | 159864107 | 2,331 | 18,467 | SH | | SOLE | | 18,467 | 0 | 0 |
Cidara Therapeutics, Inc. | Common | 171757107 | 484 | 195,256 | SH | | SOLE | | 195,256 | 0 | 0 |
Cigna Corporation | Common | 125523100 | 25,276 | 142,655 | SH | | SOLE | | 142,655 | 0 | 0 |
Clearside Biomedical, Inc. | Common | 185063104 | 281 | 165,330 | SH | | SOLE | | 165,330 | 0 | 0 |
Coherus Biosciences, Inc. | Common | 19249H103 | 1,811 | 111,663 | SH | | SOLE | | 111,663 | 0 | 0 |
Community Health Systems, Inc. | Common | 203668108 | 393 | 117,735 | SH | | SOLE | | 117,735 | 0 | 0 |
Community Healthcare Trust Incorporated | Common | 20369C106 | 570 | 14,900 | SH | | SOLE | | 14,900 | 0 | 0 |
CRISPR Therapeutics AG | Namen AKT | H17182108 | 3,233 | 76,222 | SH | | SOLE | | 76,222 | 0 | 0 |
CVS Health Corporation | Common | 126650100 | 29,546 | 497,986 | SH | | SOLE | | 497,986 | 0 | 0 |
CymaBay Therapeutics, Inc. | Common | 23257D103 | 130 | 88,102 | SH | | SOLE | | 88,102 | 0 | 0 |
Danaher Corporation | Common | 235851102 | 22,056 | 159,352 | SH | | SOLE | | 159,352 | 0 | 0 |
Deciphera Pharmaceuticals, Inc. | Common | 24344T101 | 2,527 | 61,370 | SH | | SOLE | | 61,370 | 0 | 0 |
DENTSPLY SIRONA Inc. | Common | 24906P109 | 4,455 | 114,736 | SH | | SOLE | | 114,736 | 0 | 0 |
Diversified Healthcare Trust | Common | 25525P107 | 1,299 | 357,720 | SH | | SOLE | | 357,720 | 0 | 0 |
Editas Medicine, Inc. | Common | 28106W103 | 2,582 | 130,201 | SH | | SOLE | | 130,201 | 0 | 0 |
Edwards Lifesciences Corporation | Common | 28176E108 | 12,710 | 67,382 | SH | | SOLE | | 67,382 | 0 | 0 |
Eidos Therapeutics, Inc. | Common | 28249H104 | 980 | 20,000 | SH | | SOLE | | 20,000 | 0 | 0 |
Eli Lilly and Company | Common | 532457108 | 35,883 | 258,669 | SH | | SOLE | | 258,669 | 0 | 0 |
Endo International plc | Shares | G30401106 | 1,967 | 531,570 | SH | | SOLE | | 531,570 | 0 | 0 |
Epizyme, Inc. | Common | 29428V104 | 3,222 | 207,752 | SH | | SOLE | | 207,752 | 0 | 0 |
Esperion Therapeutics, Inc. | Common | 29664W105 | 1,311 | 41,577 | SH | | SOLE | | 41,577 | 0 | 0 |
Evolent Health, Inc. | Common | 30050B101 | 1,254 | 231,027 | SH | | SOLE | | 231,027 | 0 | 0 |
Exact Sciences Corporation | Common | 30063P105 | 1,342 | 23,133 | SH | | SOLE | | 23,133 | 0 | 0 |
Exelixis, Inc. | Common | 30161Q104 | 8,870 | 515,125 | SH | | SOLE | | 515,125 | 0 | 0 |
Fate Therapeutics, Inc. | Common | 31189P102 | 3,680 | 165,672 | SH | | SOLE | | 165,672 | 0 | 0 |
FibroGen, Inc. | Common | 31572Q808 | 6,751 | 194,270 | SH | | SOLE | | 194,270 | 0 | 0 |
Five Star Senior Living Inc. | Common | 33832D205 | 67 | 24,237 | SH | | SOLE | | 24,237 | 0 | 0 |
Galapagos NV | Sponsored ADR | 36315X101 | 1,282 | 6,543 | SH | | SOLE | | 6,543 | 0 | 0 |
Galera Therapeutics, Inc. | Common | 36338D108 | 3,958 | 416,666 | SH | | SOLE | | 416,666 | 0 | 0 |
Genmab A/S | Sponsored ADS | 372303206 | 3,139 | 148,148 | SH | | SOLE | | 148,148 | 0 | 0 |
Gilead Sciences, Inc. | Common | 375558103 | 141,170 | 1,888,305 | SH | | SOLE | | 1,888,305 | 0 | 0 |
GlaxoSmithKline PLC | Shares | 37733W105 | 7,838 | 206,868 | SH | | SOLE | | 206,868 | 0 | 0 |
Global Blood Therapeutics, Inc. | Common | 37890U108 | 6,033 | 118,083 | SH | | SOLE | | 118,083 | 0 | 0 |
Global Medical REIT Inc. | Common | 37954A204 | 1,770 | 174,897 | SH | | SOLE | | 174,897 | 0 | 0 |
Grifols, S.A. | Sponsored ADR | 398438408 | 954 | 47,373 | SH | | SOLE | | 47,373 | 0 | 0 |
Guardant Health, Inc. | Common | 40131M109 | 1,646 | 23,656 | SH | | SOLE | | 23,656 | 0 | 0 |
GW Pharmaceuticals plc | ADS | 36197T103 | 4,387 | 50,101 | SH | | SOLE | | 50,101 | 0 | 0 |
Halozyme Therapeutics, Inc. | Common | 40637H109 | 1,258 | 69,917 | SH | | SOLE | | 69,917 | 0 | 0 |
HCA Healthcare, Inc. | Common | 40412C101 | 7,532 | 83,833 | SH | | SOLE | | 83,833 | 0 | 0 |
Health Care Select Sector SPDR Fund | SBI Healthcare | 81369Y209 | 891 | 10,055 | SH | | SOLE | | 10,055 | 0 | 0 |
Healthcare Realty Trust Incorporated | Common | 421946104 | 2,905 | 104,024 | SH | | SOLE | | 104,024 | 0 | 0 |
Healthcare Trust of America, Inc. | Common | 42225P501 | 1,716 | 70,662 | SH | | SOLE | | 70,662 | 0 | 0 |
HealthEquity, Inc. | Common | 42226A107 | 1,382 | 27,310 | SH | | SOLE | | 27,310 | 0 | 0 |
Healthpeak Properties, Inc. | Common | 42250P103 | 3,587 | 150,392 | SH | | SOLE | | 150,392 | 0 | 0 |
Heron Therapeutics, Inc. | Common | 427746102 | 1,540 | 131,183 | SH | | SOLE | | 131,183 | 0 | 0 |
Hologic, Inc. | Common | 436440101 | 1,143 | 32,564 | SH | | SOLE | | 32,564 | 0 | 0 |
Horizon Therapeutics plc | Shares | G46188101 | 11,826 | 399,257 | SH | | SOLE | | 399,257 | 0 | 0 |
Humana Inc. | Common | 444859102 | 14,486 | 46,130 | SH | | SOLE | | 46,130 | 0 | 0 |
IDEXX Laboratories, Inc. | Common | 45168D104 | 9,766 | 40,314 | SH | | SOLE | | 40,314 | 0 | 0 |
Illumina, Inc. | Common | 452327109 | 72,464 | 265,319 | SH | | SOLE | | 265,319 | 0 | 0 |
ImmunoGen, Inc. | Common | 45253H101 | 574 | 168,190 | SH | | SOLE | | 168,190 | 0 | 0 |
Immunomedics, Inc. | Common | 452907108 | 6,566 | 487,103 | SH | | SOLE | | 487,103 | 0 | 0 |
Incyte Corporation | Common | 45337C102 | 31,653 | 432,246 | SH | | SOLE | | 432,246 | 0 | 0 |
Inogen, Inc. | Common | 45780L104 | 2,656 | 51,406 | SH | | SOLE | | 51,406 | 0 | 0 |
Insmed Incorporated | Common | 457669307 | 1,577 | 98,387 | SH | | SOLE | | 98,387 | 0 | 0 |
Intellia Therapeutics, Inc. | Common | 45826J105 | 673 | 55,050 | SH | | SOLE | | 55,050 | 0 | 0 |
Intercept Pharmaceuticals, Inc. | Common | 45845P108 | 2,167 | 34,414 | SH | | SOLE | | 34,414 | 0 | 0 |
Intra-Cellular Therapies, Inc. | Common | 46116X101 | 1,448 | 94,238 | SH | | SOLE | | 94,238 | 0 | 0 |
Intuitive Surgical, Inc. | Common | 46120E602 | 16,856 | 34,039 | SH | | SOLE | | 34,039 | 0 | 0 |
Ionis Pharmaceuticals, Inc. | Common | 462222100 | 9,135 | 193,201 | SH | | SOLE | | 193,201 | 0 | 0 |
Iovance Biotherapeutics, Inc. | Common | 462260100 | 6,618 | 221,073 | SH | | SOLE | | 221,073 | 0 | 0 |
IQVIA Holdings Inc. | Common | 46266C105 | 8,873 | 82,266 | SH | | SOLE | | 82,266 | 0 | 0 |
Jazz Pharmaceuticals plc | Shares | G50871105 | 6,728 | 67,456 | SH | | SOLE | | 67,456 | 0 | 0 |
Johnson & Johnson | Common | 478160104 | 109,988 | 838,769 | SH | | SOLE | | 838,769 | 0 | 0 |
Kodiak Sciences Inc. | Common | 50015M109 | 1,104 | 23,153 | SH | | SOLE | | 23,153 | 0 | 0 |
Koninklijke Philips N.V. | NY Reg Sh | 500472303 | 2,241 | 55,796 | SH | | SOLE | | 55,796 | 0 | 0 |
Laboratory Corporation of America Holdings | Sponsored ADR | 50540R409 | 3,972 | 31,424 | SH | | SOLE | | 31,424 | 0 | 0 |
Ligand Pharmaceuticals Incorporated | Common | 53220K504 | 2,225 | 30,590 | SH | | SOLE | | 30,590 | 0 | 0 |
LTC Properties, Inc. | Common | 502175102 | 5,633 | 182,293 | SH | | SOLE | | 182,293 | 0 | 0 |
Madrigal Pharmaceuticals, Inc. | Common | 558868105 | 891 | 13,340 | SH | | SOLE | | 13,340 | 0 | 0 |
Magenta Therapeutics, Inc. | Common | 55910K108 | 105 | 16,757 | SH | | SOLE | | 16,757 | 0 | 0 |
Mallinckrodt plc | Sponsored ADR | G5785G107 | 65 | 32,980 | SH | | SOLE | | 32,980 | 0 | 0 |
McKesson Corporation | Common | 58155Q103 | 8,051 | 59,525 | SH | | SOLE | | 59,525 | 0 | 0 |
Medical Properties Trust, Inc. | Common | 58463J304 | 7,119 | 411,743 | SH | | SOLE | | 411,743 | 0 | 0 |
Medpace Holdings, Inc. | Common | 58506Q109 | 1,385 | 18,871 | SH | | SOLE | | 18,871 | 0 | 0 |
Medtronic plc | Shares | G5960L103 | 40,311 | 447,011 | SH | | SOLE | | 447,011 | 0 | 0 |
Menlo Therapeutics Inc. | Common | 586858102 | 478 | 178,181 | SH | | SOLE | | 178,181 | 0 | 0 |
Merck & Co., Inc. | Common | 58933Y105 | 78,679 | 1,022,596 | SH | | SOLE | | 1,022,596 | 0 | 0 |
Merus N.V. | Common | N5749R100 | 257 | 21,215 | SH | | SOLE | | 21,215 | 0 | 0 |
Mettler-Toledo International Inc. | Common | 592688105 | 4,228 | 6,123 | SH | | SOLE | | 6,123 | 0 | 0 |
Milestone Pharmaceuticals Inc. | Common | 59935V107 | 392 | 213,310 | SH | | SOLE | | 213,310 | 0 | 0 |
Mirati Therapeutics, Inc. | Common | 60468T105 | 6,056 | 78,784 | SH | | SOLE | | 78,784 | 0 | 0 |
Moderna, Inc. | Common | 60770K107 | 7,612 | 254,146 | SH | | SOLE | | 254,146 | 0 | 0 |
Molecular Templates, Inc. | Common | 608550109 | 562 | 42,313 | SH | | SOLE | | 42,313 | 0 | 0 |
Momenta Pharmaceuticals, Inc. | Common | 60877T100 | 2,484 | 91,316 | SH | | SOLE | | 91,316 | 0 | 0 |
MorphoSys AG | Sponsored ADS | 617760202 | 476 | 19,390 | SH | | SOLE | | 19,390 | 0 | 0 |
Mylan N.V. | Shares | N59465109 | 15,070 | 1,010,754 | SH | | SOLE | | 1,010,754 | 0 | 0 |
MyoKardia, Inc. | Common | 62857M105 | 905 | 19,300 | SH | | SOLE | | 19,300 | 0 | 0 |
National Health Investors, Inc. | Common | 63633D104 | 497 | 10,038 | SH | | SOLE | | 10,038 | 0 | 0 |
Nektar Therapeutics | Common | 640268108 | 4,696 | 263,079 | SH | | SOLE | | 263,079 | 0 | 0 |
Neurocrine Biosciences, Inc. | Common | 64125C109 | 17,842 | 206,150 | SH | | SOLE | | 206,150 | 0 | 0 |
New Senior Investment Group Inc. | Common | 648691103 | 656 | 256,398 | SH | | SOLE | | 256,398 | 0 | 0 |
Novartis AG | Sponsored ADR | 66987V109 | 14,828 | 179,847 | SH | | SOLE | | 179,847 | 0 | 0 |
Novavax, Inc. | Common | 670002401 | 388 | 28,550 | SH | | SOLE | | 28,550 | 0 | 0 |
Novo Nordisk A/S | Sponsored ADR | 670100205 | 8,067 | 134,005 | SH | | SOLE | | 134,005 | 0 | 0 |
NovoCure Ltd. | Ordinary Shares | G6674U108 | 7,235 | 107,438 | SH | | SOLE | | 107,438 | 0 | 0 |
Omega Healthcare Investors, Inc. | Common | 681936100 | 8,133 | 306,433 | SH | | SOLE | | 306,433 | 0 | 0 |
Ovid Therapeutics Inc. | Sponsored ADR | 690469101 | 1,111 | 372,733 | SH | | SOLE | | 372,733 | 0 | 0 |
Pacific Biosciences of California, Inc. | Common | 69404D108 | 1,516 | 495,495 | SH | | SOLE | | 495,495 | 0 | 0 |
PerkinElmer, Inc. | Common | 714046109 | 2,898 | 38,494 | SH | | SOLE | | 38,494 | 0 | 0 |
Perrigo Company plc | Shares | G97822103 | 520 | 10,818 | SH | | SOLE | | 10,818 | 0 | 0 |
Pfizer Inc. | Common | 717081103 | 59,413 | 1,820,248 | SH | | SOLE | | 1,820,248 | 0 | 0 |
Physicians Realty Trust | Common | 71943U104 | 6,911 | 495,733 | SH | | SOLE | | 495,733 | 0 | 0 |
Pieris Pharmaceuticals, Inc. | Common | 720795103 | 3,304 | 1,449,269 | SH | | SOLE | | 1,449,269 | 0 | 0 |
Portola Pharmaceuticals, Inc. | Sponsored ADR | 737010108 | 779 | 109,246 | SH | | SOLE | | 109,246 | 0 | 0 |
PRA Health Sciences, Inc. | Common | 69354M108 | 11,917 | 143,508 | SH | | SOLE | | 143,508 | 0 | 0 |
PTC Therapeutics, Inc. | Common | 69366J200 | 5,390 | 120,827 | SH | | SOLE | | 120,827 | 0 | 0 |
Puma Biotechnology, Inc. | Common | 74587V107 | 602 | 71,340 | SH | | SOLE | | 71,340 | 0 | 0 |
Quest Diagnostics Incorporated | Common | 74834L100 | 1,688 | 21,025 | SH | | SOLE | | 21,025 | 0 | 0 |
Quorum Health Corporation | Common | 74909E106 | 11 | 23,725 | SH | | SOLE | | 23,725 | 0 | 0 |
Quotient Ltd. | Common | G73268107 | 1,027 | 260,030 | SH | | SOLE | | 260,030 | 0 | 0 |
Ra Pharmaceuticals, Inc. | Common | 74933V108 | 1,716 | 35,743 | SH | | SOLE | | 35,743 | 0 | 0 |
Reata Pharmaceuticals, Inc. | Class A | 75615P103 | 5,071 | 35,129 | SH | | SOLE | | 35,129 | 0 | 0 |
Regeneron Pharmaceuticals, Inc. | Common | 75886F107 | 83,438 | 170,878 | SH | | SOLE | | 170,878 | 0 | 0 |
REGENXBIO Inc. | Common | 75901B107 | 703 | 21,700 | SH | | SOLE | | 21,700 | 0 | 0 |
ResMed Inc. | Common | 761152107 | 2,626 | 17,831 | SH | | SOLE | | 17,831 | 0 | 0 |
Revance Therapeutics, Inc. | Common | 761330109 | 1,270 | 85,840 | SH | | SOLE | | 85,840 | 0 | 0 |
Rocket Pharmaceuticals, Inc. | Common | 77313F106 | 2,895 | 207,555 | SH | | SOLE | | 207,555 | 0 | 0 |
Rubius Therapeutics, Inc. | Common | 78116T103 | 694 | 155,982 | SH | | SOLE | | 155,982 | 0 | 0 |
Sabra Health Care REIT, Inc. | Common | 78573L106 | 5,576 | 510,660 | SH | | SOLE | | 510,660 | 0 | 0 |
Sage Therapeutics Inc | Common | 78667J108 | 2,763 | 96,211 | SH | | SOLE | | 96,211 | 0 | 0 |
Sangamo Therapeutics, Inc. | Common | 800677106 | 954 | 149,835 | SH | | SOLE | | 149,835 | 0 | 0 |
Sanofi | Sponsored ADR | 80105N105 | 14,312 | 327,367 | SH | | SOLE | | 327,367 | 0 | 0 |
Sarepta Therapeutics, Inc. | Common | 803607100 | 13,707 | 140,129 | SH | | SOLE | | 140,129 | 0 | 0 |
Seattle Genetics, Inc. | Common | 812578102 | 24,752 | 214,530 | SH | | SOLE | | 214,530 | 0 | 0 |
Smith & Nephew plc | Shares | 83175M205 | 3,571 | 99,560 | SH | | SOLE | | 99,560 | 0 | 0 |
Spectrum Pharmaceuticals, Inc. | Common | 84763A108 | 267 | 114,670 | SH | | SOLE | | 114,670 | 0 | 0 |
STERIS plc | Shares | G8473T100 | 1,570 | 11,218 | SH | | SOLE | | 11,218 | 0 | 0 |
Stryker Corporation | Common | 863667101 | 22,609 | 135,795 | SH | | SOLE | | 135,795 | 0 | 0 |
Sutro Biopharma, Inc. | Common | 869367102 | 6,541 | 641,268 | SH | | SOLE | | 641,268 | 0 | 0 |
Syneos Health, Inc. | Class A | 87166B102 | 4,257 | 108,001 | SH | | SOLE | | 108,001 | 0 | 0 |
Takeda Pharmaceutical Company Ltd. | Sponsored ADS | 874060205 | 3,190 | 210,146 | SH | | SOLE | | 210,146 | 0 | 0 |
Teleflex Incorporated | Common | 879369106 | 5,052 | 17,252 | SH | | SOLE | | 17,252 | 0 | 0 |
Tenet Healthcare Corporation | Common | 88033G407 | 1,393 | 96,736 | SH | | SOLE | | 96,736 | 0 | 0 |
Tetraphase Pharmaceuticals, Inc. | Common | 88165N204 | 55 | 42,965 | SH | | SOLE | | 42,965 | 0 | 0 |
Teva Pharmaceutical Industries Ltd. | Sponsored ADR | 881624209 | 7,057 | 785,851 | SH | | SOLE | | 785,851 | 0 | 0 |
Theravance Biopharma, Inc. | Common | G8807B106 | 5,288 | 228,836 | SH | | SOLE | | 228,836 | 0 | 0 |
Thermo Fisher Scientific Inc. | Common | 883556102 | 31,770 | 112,025 | SH | | SOLE | | 112,025 | 0 | 0 |
Trillium Therapeutics Inc. | Common | 89620X506 | 1,810 | 448,049 | SH | | SOLE | | 448,049 | 0 | 0 |
Turning Point Therapeutics, Inc. | Common | 90041T108 | 254 | 5,677 | SH | | SOLE | | 5,677 | 0 | 0 |
Ultragenyx Pharmaceutical Inc. | Common | 90400D108 | 4,331 | 97,480 | SH | | SOLE | | 97,480 | 0 | 0 |
uniQure N.V. | Shares | N90064101 | 2,081 | 43,849 | SH | | SOLE | | 43,849 | 0 | 0 |
United Therapeutics Corporation | Class B | 91307C102 | 6,023 | 63,513 | SH | | SOLE | | 63,513 | 0 | 0 |
Unitedhealth Group Incorporated | Common | 91324P102 | 56,566 | 226,827 | SH | | SOLE | | 226,827 | 0 | 0 |
Universal Health Realty Income Trust | Shares | 91359E105 | 1,135 | 11,258 | SH | | SOLE | | 11,258 | 0 | 0 |
Ventas, Inc. | Common | 92276F100 | 5,577 | 208,108 | SH | | SOLE | | 208,108 | 0 | 0 |
Verona Pharma plc | Sponsored ADR | 925050106 | 1,043 | 253,179 | SH | | SOLE | | 253,179 | 0 | 0 |
Vertex Pharmaceuticals Incorporated | Common | 92532F100 | 115,579 | 485,730 | SH | | SOLE | | 485,730 | 0 | 0 |
Viela Bio, Inc. | Common | 926613100 | 19 | 500 | SH | | SOLE | | 500 | 0 | 0 |
Waters Corporation | Common | 941848103 | 4,733 | 26,000 | SH | | SOLE | | 26,000 | 0 | 0 |
WaVe Life Sciences Ltd. | Shares | Y95308105 | 1,201 | 128,146 | SH | | SOLE | | 128,146 | 0 | 0 |
Welltower Inc. | Common | 95040Q104 | 9,297 | 203,083 | SH | | SOLE | | 203,083 | 0 | 0 |
Xencor, Inc. | Common | 98401F105 | 4,429 | 148,231 | SH | | SOLE | | 148,231 | 0 | 0 |
Y-mAbs Therapeutics, Inc. | Common | 984241109 | 1,998 | 76,548 | SH | | SOLE | | 76,548 | 0 | 0 |
Zai Lab Ltd. | ADR | 98887Q104 | 1,932 | 37,523 | SH | | SOLE | | 37,523 | 0 | 0 |
Zimmer Biomet Holdings, Inc. | Common | 98956P102 | 7,901 | 78,168 | SH | | SOLE | | 78,168 | 0 | 0 |
Zoetis Inc. | Class A | 98978V103 | 17,883 | 151,952 | SH | | SOLE | | 151,952 | 0 | 0 |
Zogenix, Inc. | Common | 98978L204 | 5,327 | 215,406 | SH | | SOLE | | 215,406 | 0 | 0 |
Zymeworks Inc. | Common | 98985W102 | 539 | 15,192 | SH | | SOLE | | 15,192 | 0 | 0 |